Sage Journals: Discover world-class research

Retricted access

Research article

First published 2016-1

Drugs and bioethics in the field of nephrology

Mario Timio, Francesca Timio

Giornale di Tecniche Nefrologiche e Dialitiche

Retricted access

Research article

First published 2008-10

Desvenlafaxine: Another “Me Too” Drug?

Michael A Sopko, Megan J Ehret, Marina Grgas

Annals of Pharmacotherapy

Retricted access

Research article

First published 2006-6

How Many “Me-Too” Drugs are Enough? The Case of Physician Preferences for Specific Statins

Peter C Austin, Muhammad M Mamdani, David N Juurlink

Annals of Pharmacotherapy

Retricted access

Other

First published 2002-11

Commentary: Making "Me-too" Drugs Benefit the Public

Neil J. Nusbaum

American Journal of Medical Quality

Retricted access

Research article

First published 2013-1

Proteolix: A “Me-Too” Success

Larry Lasky, Victoria Chang

California Management Review

Retricted access

Research article

First published 2011-2

The growing role of pharmacoeconomic evaluations and their impact on the European pharmaceutical industry

Marcus Oehlrich

Pharmaceuticals Policy and Law

Retricted access

Research article

First published 2010-7

Medicine for Tomorrow: Some Alternative Proposals to Promote Socially Beneficial Research and Development in Pharmaceuticals

Joseph E. Stiglitz, Arjun Jayadev

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Retricted access

Research article

First published 2009-8

Therapeutic Interchange Practices among Texas Medical Center Institutions

Aisha Morris Moultry, Sonya R. Wilmer

Hospital Pharmacy

Search results